Salivary and Sinonasal Tumors: Multi-Disciplinary Individualization of Patient Care
Sinonasal and salivary malignancies are less common head and neck tumors but are still frequently seen by radiation oncologists and pose complex clinical decision making challenges due to the proximity to the facial nerve, optic structures, brain, and oral cavity.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas
Recently, there have been exciting advances in the treatment of relapsed/refractory (R/R) lymphomas. Historically, the standard-of-care included salvage chemotherapy followed by autologous stem cell transplantation (ASCT). Today, many other salvage options are available.
Category
  • General RO
  • Head and Neck
  • Hematologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Prophylactic Feeding Tube Placement in Head and Neck Cancer: Hard to Swallow?
The clinical practice regarding feeding tube use in patients undergoing radiotherapy for head and neck cancer varies greatly. Ongoing research advances, as well as indications for feeding tube use in contemporary practices are required to provide optimal care.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Head and Neck Cancer - Prevention and Management of Radiation Therapy Toxicity in the Community Setting
Patients with head and neck cancer require specialized and multi-modality support during treatment. Providers may not be informed of the most up-to-date techniques to prevent and treat head and neck cancer radiation-related toxicity.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Integration of HPV ctDNA Testing into Clinical Practice for HPV+ OPSCC – Ready for Prime Time?
The use of HPV ctDNA in the clinical management of patients with HPV-associated oropharyngeal squamous cell carcinoma is rapidly increasing; however, questions remain regarding its utility and validity in various clinical settings.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
A Case-Based Interactive Discussion of the ASTRO Clinical Practice Guideline for HPV-Positive Oropharyngeal Squamous Cell Carcinoma
This case-based activity is designed to provide learners with practical guidance on management of HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) and highlight areas of uncertainty where there may be a range of acceptable treatment approaches.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Science Highlights 2024: Head and Neck Cancer
This session highlights the most clinically relevant abstracts within the Head and Neck Cancer track of the 2024 ASTRO Annual Meeting scientific program. These noteworthy scientific abstracts share important findings and feature cutting-edge research from leaders in the field.
Category
  • Head and Neck
Format
  • Sessions onDemand
Credits
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Certificate of Attendance
Cost $79.00